Medscape |
Most New Cancer Drugs Don't Improve Survival or QoL
Medscape The majority of new oncology drugs that were approved by the European Medicines Agency (EMA) from 2009 to 2013 entered the market without clear evidence that they improved survival or quality of life, according to a new report published online October ... Study Questions European Approval Process for Cancer Drugs More than half of cancer drugs may not work, study suggests Over half of new cancer drugs 'show no benefits' for survival or wellbeing |
from Health - Google News http://ift.tt/2xklLzm
EmoticonEmoticon